US Oncology Reports Second Quarter Operating Results
... growth. We are also experiencing a shift toward generic alternatives for certain oncology pharmaceuticals ... We expect that this trend toward greater use of generic oncology drugs will continue for the foreseeable ... outstanding, as well as payments made under a generic drug inventory management program in the second ...Cambrex Reports Second Quarter 2009 Results
... offsetting these increases were lower sales of generic APIs and feed additives. Custom development ... partially offset by lower volume and pricing of generic APIs. Selling, General and Administrative ... we are seeing price and volume pressure on our generic APIs due to competitive supply chain dynamics. ...Par Pharmaceutical Reports EPS of $0.71 for Second Quarter 2009
... the second quarter. Par is the authorized generic for all strengths of AstraZeneca's Toprol(R) XL. ... Par remained the exclusive supplier of generic Imitrex(R) 4mg and 6mg starter kits and 4mg ... pricing pressures. Other generic products: For the second quarter 2009, net sales ...Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG
... succinate extended-release tablets are the generic equivalent to AstraZeneca's Toprol XL(R) tablets. ... Toprol XL(R) 25 mg and 50 mg and its generic equivalents had annual sales of approximately ... of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand ...Caraco Pharmaceutical Laboratories, Ltd. Announces Settlement of Ethyol(R) ANDA Patent Litigation
... an Abbreviated New Drug Application (ANDA) for a generic version of Ethyol(R). Under the settlement ... permitting Caraco to continue marketing a generic version of Ethyol(R) in the United States. The ... develops, manufactures, markets and distributes generic and private-label pharmaceuticals to the nation's ...Teva's Forum Draws Key Pennsylvania Healthcare Leaders
... -- Teva Pharmaceuticals USA, the world's leading generic pharmaceutical company, today hosted the last in ... -- including the development of a pathway for generic biologic medicines. About Teva USA ... companies in the world and is the world's leading generic pharmaceutical company. The Company develops, ...Cardinal Health Welcomes Record Number of Attendees at its Annual Independent Pharmacy Trade Show
... care costs will continue to drive demand for generic products. To enable retail independents to make generic drugs immediately available to patients, Cardinal ... participating pharmacies a 30-day supply of new generic pharmaceuticals, immediately upon each product's ...Valeant to Acquire Tecnofarma, A Mexican Generic Company
... one times sales. Tecnofarma is a producer of generic pharmaceuticals which has approximately $33 ... products that can be introduced into the branded generic market in Mexico. "The acquisition of ... current market focus on the commercial branded generic market. Adding two well-established businesses ...ViroPharma Incorporated Reports Second Quarter 2009 Financial Results
... approach considered for use in approving generic formulations of Vancocin that does not require ... citizen petition for Vancocin or the approval of generic versions of Vancocin. If we are unable to change ... forth by the FDA in December 2008, the threat of generic competition will be high. The entry of ...Mylan Announces Enhancements to Executive Management Team
... for these areas and also oversee the company's generic biologics efforts as well as those initiatives ... Prior to Mylan, Malik has over 25 years of global generic pharmaceutical industry experience in leadership ... enjoys an exemplary 16-year track record in the generic pharmaceutical industry, primarily in commercial ...Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R)
... Pharmaceuticals, Inc. (NYSE: WPI ), a leader in generic and specialty branded pharmaceuticals, today ... Inc., for the exclusive US marketing rights to a generic version of Ferrlecit (sodium ferric gluconate ... of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of branded ...Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance
... preliminary injunction to prevent the launch of a generic version of Evista((R)) by Teva Pharmaceuticals ... U.S. was favorably impacted by the withdrawal of generic competition in Germany. Cymbalta ... and lower prices as a result of the entry of generic competition in most major markets, as well as the ...FDA Accepts Tris Pharma's ANDA with Paragraph IV Certification for a Generic Equivalent to Delsym
... polistirex suspension will be the generic version of Reckitt Benckiser's Delsym. ... Tris Pharma's ANDA seeking approval for a generic version of Delsym was filed earlier this year, ... an ANDA with a paragraph IV certification for a generic version of Delsym, and should its product be ...Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR(R)
... chloride extended-release capsules are the generic version of Allergan Inc.'s Sanctura XR((R))( ... believes it may be first to file an ANDA for generic trospium extended-release capsules. For the ... of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand ...Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009
... the expected decline in Depakote(R) sales due to generic competition, worldwide operational sales ... Sales comparison reflects the expected impact of generic Depakote competition. See Q&A Answer ... Sales comparison reflects the expected impact of generic Depakote competition. See Q&A Answer ...Brazil proves developing countries can use generic medicines to fight HIV/AIDS epidemic
... can successfully combat the epidemic. Inexpensive generic medicines are a large part of the solution, say ... drugs to lower their prices dramatically and generic companies to develop lower-cost alternatives for ... AIDS treatment. The country also began producing generic AIDS medicines in public factories. Brazilian ...HealthWarehouse.com Announces $3.50 Prescription Drug Program
... it will offer a 30-day supply of over 300 popular generic prescription drugs for $3.50. With outstanding ... Pricing of $3.50 for a 30-day supply of generic prescription medications Pricing of $9.50 for a 90-day supply of generic prescription medications Coverage of ...High Rx Costs Hammering Illinois' 50+ Population
... marked the largest price jump in six years, while generic drug prices decreased by nearly 11%. ... the largest price increases at 9.3%. Currently, generic versions of these drugs are not available, ... 726), which would allow consumers access to generic versions of expensive biologic drugs. The ...Consumer Reports to Parents: Think Twice About Free Prescription ADHD Drug Samples for Your Children
... are not any better or safer than less expensive generic medicines. In addition, when doctors give out ... Consumer Reports Best Buy Drugs found that two generic ADHD drugs, dextroamphetamine and ... or Strattera. By switching to one of those two generic drugs, consumers could save roughly $3,000 a year ...Watson Pharmaceuticals Receives FDA Approval for Fruit and Cinnamon Flavored Coated Nicotine Gums
... Pharmaceuticals, Inc. (NYSE: WPI ), a leader in generic and specialty branded pharmaceuticals, today ... Gum coated fruit and cinnamon flavors are the generic equivalent of GlaxoSmithKline Consumer ... of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand ...Crestor Patent Invalidity Evidence Uncovered By Article One Partners Community
... can impact the industry litigation to market generic rosuvastatin drugs. The prior art (further ... Crestor Study & Industry Impact Nine generic drug manufacturers have submitted Abbreviated New ... Administration (FDA), seeking approval to market generic versions of Crestor. AstraZeneca countered with ...Hospira Receives FDA Approval for Azithromycin for Injection
... Hospira, Inc. (NYSE: HSP ), the world leader in generic injectable pharmaceuticals, today announced it ... System. The anti-infective medication is a generic version of Pfizer's Zithromax(R) for injection. U.S. sales of generic and name-brand azithromycin for injection were ...America Speaks Out in Favor of Affordable Healthcare and Biogenerics in Teva's Fourth Video
... -- Teva Pharmaceuticals USA, the leading generic pharmaceutical company, today released its fourth ... is meant to illustrate the important savings generic drugs have produced for everyday Americans since ... campaign to recognize the important role that generic drugs play in providing competitive and more ...Putney, Inc. Enters the $175M Annual Veterinary NSAID Market
... company focused on the development of generic drugs for pets, has launched carprofen caplets, a bioequivalent generic version of the canine medication Rimadyl(R) ... that they would feel comfortable switching to generic carprofen caplets and 88% believe that pet owners ...Glen's Markets Adds Discounted Generic Drug Program
... northern Michigan are pleased to now offer a generic drug program for 30 day prescriptions for $4 and ... new programs offering lower prices on over 300 generic drugs to meet the healthcare needs and healthcare ... challenging economic times. "Our expanded generic drug program is another example of the many ways ...